Elevated CA 15-3, Stage 3, without metastases
Hello everyone,
July 2024 – Diagnosis: breast cancer ER+ / HER2 negative, with lymph node involvement, no metastases, stage IIIA. I had a CT, MRI, and PET-CT before starting chemotherapy.
August 2024 – I started chemotherapy, but before that I measured CA 15-3, which was elevated at 74 U/ml. It increased up to 92 halfway through the treatment, but returned to normal limits after I finished chemotherapy (24 U/ml).
After chemo, I had surgery, and before starting radiotherapy I checked it again – it was 21 U/ml. The next measurement was done 6 weeks after radiotherapy, before starting the first cycle of Ribociclib, and CA 15-3 had risen slightly to 24 U/ml.
I started Ribociclib preventively, because I have a high risk of recurrence. I tested the marker again after the first cycle of Ribociclib, when it had increased to 29, and again after the second cycle of Ribociclib, when it rose to 34.6 U/ml.
These increases make me quite anxious.
Are there other people in stage III who have experienced a rise in tumor marker after starting Ribociclib (Kisquali) or Abemaciclib (Verzenio), without this being associated with the appearance of metastases?
Wishing you all good health!
Comments
-
Bumping for those with same…
Hello, sorry for your experiences. Naturally, not meeting expectations can and will cause anxiety. Read below. Wishing you peace and comfort. Hugs!
"WHAT LEVEL OF CA 15-3 INDICATES CANCER?
A single elevated reading is not definitive for diagnosis; it is interpreted alongside other clinical information, imaging studies, and patient history.
"Gynecological conditions can also contribute to elevated CA 15-3 levels. These include ovarian cysts, endometriosis and pelvic inflammatory disease."
"The “normal” reference range for CA 15-3 levels is generally less than 30 Units per milliliter (U/mL). Note that this upper limit can vary slightly between different laboratories and the specific testing kits they use. Results from different labs should not be directly compared."
"An elevated CA 15-3 level does not automatically signify the presence of cancer. Many non-cancerous conditions can also lead to increased CA 15-3 levels."
CA15-3 (CANCER ANTIGEN 15-3)
"CA 15-3 is elevated in about 30% of women with localised breast cancer and in about 75%... that has metastasised."
"25% to 30% of individuals with advanced breast cancer have tumours that do not produce CA 15-3."
"Levels of CA 15-3 are not usually taken immediately after breast cancer treatment begins because there have been instances of temporary increases in CA 15-3 that do not match with the patient’s progress."
0